Client News

AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia
12/08/2008

Targacept, Inc.

Targacept Announces Conference Call to be Held Today at 5:30 p.m. and Updates Guidance
12/08/2008

Targacept, Inc.

ImmunoGen, Inc. Announces Webcast of Panel Session at the RBC Capital Markets 2008 Healthcare Conference
12/04/2008

ImmunoGen, Inc.

Data Demonstrating Significant Efficacy of Viread(R) in Treating Chronic Hepatitis B Published in New England Journal of Medicine
12/03/2008

Gilead Sciences, Inc.

MAKO Surgical Corp. Receives FDA Clearance to Market Both its Version 2.0 Tactile Guidance System ™ and its Bicompartmental Knee Resurfacing Implant System
12/02/2008

Montreux Equity Partners.